erythromycin ethylsuccinate has been researched along with erythromycin stearate in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (38.46) | 18.7374 |
| 1990's | 7 (53.85) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dajani, AS; Taubert, KA | 1 |
| Sandor, GK; Vasilakos, JS; Vasilakos, SS | 1 |
| Carter, BL; Cole, KJ; Milavetz, G; Woodhead, JC | 1 |
| Hellum, KB; Walstad, RA | 1 |
| McNabb, WR; Shanson, DC; Tadayon, M; Tidbury, P | 1 |
| De Schepper, PJ; Josefsson, K; Mullie, A; Tjandramaga, TB; Van Hecken, A; Verbesselt, R; Verbist, L | 1 |
| McCrea, PH; McGimpsey, JG; Webb, CH | 1 |
| Aoyama, T; Goto, A; Iwai, H; Kawai, H; Murase, Y | 1 |
| Amin, AS; Issa, YM | 1 |
| Aglas, F; Horina, JH; Horn, S | 1 |
1 review(s) available for erythromycin ethylsuccinate and erythromycin stearate
| Article | Year |
|---|---|
Mitral valve prolapse: a review of the syndrome with emphasis on current antibiotic prophylaxis.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Dental Care for Disabled; Endocarditis, Bacterial; Erythromycin; Erythromycin Ethylsuccinate; Humans; Mitral Valve Prolapse; Penicillin V; Premedication; Sepsis; Streptococcal Infections | 1991 |
3 trial(s) available for erythromycin ethylsuccinate and erythromycin stearate
| Article | Year |
|---|---|
Relative bioavailability of enteric coated pellets, stearate and ethylsuccinate formulations of erythromycin.
Topics: Adult; Biological Assay; Biological Availability; Capsules; Erythromycin; Erythromycin Ethylsuccinate; Humans; Intestinal Absorption; Kinetics; Male | 1984 |
Comparison of serum erythromycin concentration following administration of 100 mg erythromycin ethyl succinate intramuscularly and 500 mg erythromycin stearate orally.
Topics: Administration, Oral; Adult; Erythromycin; Erythromycin Ethylsuccinate; Female; Humans; Injections, Intramuscular; Male; Time Factors | 1981 |
Evaluation of pertussis treatment with erythromycin ethylsuccinate and stearate according to age.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Child; Child, Preschool; Drug Administration Schedule; Erythromycin; Erythromycin Ethylsuccinate; Female; Humans; Infant; Male; Whooping Cough | 1994 |
9 other study(ies) available for erythromycin ethylsuccinate and erythromycin stearate
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Re: Letter to the editor by Dr. Steven M. Pollack and author's response from Drs. Thomas J. Pallasch and Jorgen Slots. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the American Heart Association.
Topics: American Heart Association; Endocarditis, Bacterial; Erythromycin; Erythromycin Ethylsuccinate; Humans; Periodontics; United States | 1992 |
Erythromycin dosing error in bacterial endocarditis.
Topics: American Hospital Association; Dental Care for Disabled; Dose-Response Relationship, Drug; Endocarditis, Bacterial; Erythromycin; Erythromycin Ethylsuccinate; Humans; Therapeutic Equivalency; United States | 1991 |
Prevention of bacterial endocarditis.
Topics: Endocarditis, Bacterial; Erythromycin; Erythromycin Ethylsuccinate; Humans; Urinary Bladder, Neurogenic; Urinary Catheterization | 1991 |
Gastrointestinal side effects with erythromycin preparations.
Topics: Adolescent; Adult; Aged; Child; Erythromycin; Erythromycin Ethylsuccinate; Gastrointestinal Diseases; Humans; Middle Aged; Tablets, Enteric-Coated | 1987 |
Penetration of erythromycin in respiratory tract infections.
Topics: Bacterial Infections; Biological Availability; Dose-Response Relationship, Drug; Erythromycin; Erythromycin Ethylsuccinate; Humans; Kinetics; Metabolic Clearance Rate; Respiratory Tract Infections | 1984 |
The pharmacokinetics and tolerance of oral erythromycin stearate compared with erythromycin ethylsuccinate: implications for preventing endocarditis.
Topics: Administration, Oral; Adult; Endocarditis, Bacterial; Erythromycin; Erythromycin Ethylsuccinate; Female; Humans; Kinetics; Male; Middle Aged; Nausea | 1984 |
Selective spectrophotometric method for the determination of erythromycin and its esters in pharmaceutical formulations using gentiana violet.
Topics: Anti-Bacterial Agents; Dosage Forms; Erythromycin; Erythromycin Ethylsuccinate; Gentian Violet; Spectrophotometry, Ultraviolet | 1996 |
Cholestasis and liver cell damage due to hypersensitivity to erythromycin stearate--recurrence following therapy with erythromycin succinate.
Topics: Adult; Anti-Bacterial Agents; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Drug Hypersensitivity; Erythromycin; Erythromycin Ethylsuccinate; Female; Humans; Recurrence; Retreatment; Structure-Activity Relationship | 1999 |